CorVel (NASDAQ:CRVL – Get Free Report) posted its quarterly earnings results on Tuesday. The business services provider reported $0.46 earnings per share for the quarter, Zacks reports. CorVel had a net margin of 9.64% and a return on equity of 31.73%.
CorVel Price Performance
Shares of NASDAQ:CRVL traded down $2.53 during mid-day trading on Thursday, hitting $125.93. The company had a trading volume of 6,832 shares, compared to its average volume of 104,312. The company has a market capitalization of $6.42 billion, a PE ratio of 80.21 and a beta of 1.16. The firm has a fifty day moving average price of $123.83 and a 200 day moving average price of $112.27. CorVel has a one year low of $76.20 and a one year high of $128.61.
Analyst Ratings Changes
Separately, StockNews.com downgraded shares of CorVel from a “buy” rating to a “hold” rating in a research note on Friday, January 3rd.
Insider Buying and Selling at CorVel
In other CorVel news, EVP Mark E. Bertels sold 1,050 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were sold at an average price of $119.12, for a total transaction of $125,072.50. Following the completion of the sale, the executive vice president now owns 2,580 shares in the company, valued at approximately $307,321. The trade was a 28.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 47.57% of the stock is currently owned by company insiders.
CorVel Company Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
- Five stocks we like better than CorVel
- Learn Technical Analysis Skills to Master the Stock Market
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- About the Markup Calculator
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- How to Buy Cheap Stocks Step by Step
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.